Avalon Ventures

Showing 1 posts of 1 posts found.

GlaxoSmithKline acquires Sitari Pharmaceuticals after progress in coeliac disease

September 11, 2019
Research and Development, Sales and Marketing Avalon Ventures, GSK, coeliac disease

Avalon Ventures has announced that it has entered into a definitive agreement with GSK for the acquisition of Sitari Pharmaceuticals …

Latest content